Acute liver failure from anti-tuberculosis drug-induced liver injury: An update

doi:10.4254/wjh.v17.i5.106618

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1121)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

HTML

756

Figures (1-2)

128

Tables (1-2)

136

Sum=1048

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=24

May 27, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. May 27, 2025; 17(5): 106618
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.106618

Full Size Figure Download Figure

Figure 2 Diagrammatic representation of the magnitude of anti-tuberculosis drug-induced liver injury, its progression to anti-tuberculosis drug-induced acute liver failure, and subsequent patients’ outcomes. RIF: Rifampicin; INH: Isoniazid; PYZ: Pyrazinamide; ATD: Anti-tuberculosis drug; AT-DILI: Anti-tuberculosis drug-induced liver injury; AT-ALF: Anti-tuberculosis drug induced acute liver failure; LT: Liver transplantation; HE: Hepatic encephalopathy.

Citation: Kumar R, Kumar A, Kumar S. Acute liver failure from anti-tuberculosis drug-induced liver injury: An update. World J Hepatol 2025; 17(5): 106618
URL: https://www.wjgnet.com/1948-5182/full/v17/i5/106618.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i5.106618